Method and articles for treatment of stress urinary incontinence

• US 9,084,664 B2
• Filed: 05/21/2007
• Issued: 07/21/2015
• Est. Priority Date: 05/19/2006
• Status: Expired due to Fees

• Current Assignee: Boston Scientific Scimed (Boston Scientific Corporation)
• Original Assignee: Ams Research Corporation (Endo International PLC)
• Inventors: Otte, John Fritz, Lund, Robert E., Buysman, John Jason, Koullick, Edouard A., Longhini, Ross A., Presthus, James B.
• Primary Examiner(s): Hicks, Victoria J
• Application Number:
  US12/227,426
• Publication Number:
  US 20100010631A1
• Time in Patent Office: 2,983 Days
• Field of Search: 600/30
• US Class Current: 1/1
• CPC Class Codes: A61B 17/06109 Big needles, either gripped by hand or connectable to a handle
• CPC Class Codes: A61B 2017/00805 Treatment of female stress urinary incontinence
• CPC Class Codes: A61F 2/0004 Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse
• CPC Class Codes: A61F 2/0036 implantable A61F2/0018 takes precedence
• CPC Class Codes: A61F 2/0045 Support slings
• CPC Class Codes: A61F 2/08 Muscles; Tendons; Ligaments sutures A61B17/04
• CPC Class Codes: A61F 2210/0004 bioabsorbable
• CPC Class Codes: A61F 2220/0016 with sharp anchoring protrusions, e.g. barbs, pins, spikes
• CPC Class Codes: A61L 27/50 Materials characterised by their function or physical properties , e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
• CPC Class Codes: A61L 31/14 Materials characterised by their function or physical properties , e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials

Abstract

Improved methods and apparatuses for treatment of incontinence or pelvic organ prolapse are provided. A neo ligament for increasing the supportive function of the tissues supporting the urethra, bladder neck, or rectum is disclosed. Methods of using such a neoligament to treat incontinence are disclosed. Additionally, a self tensioning elastic tissue bolster for support of the tissues that support the urethra, rectum, and bladder neck are disclosed. A method of treating incontinence by injecting proliferative agents into supportive structures is disclosed. Methods and apparatus for transvaginal and transperineal pelvic floor bolster treatment of incontinence and bladder pillar systems are also disclosed.

Claims

1. A method of treating urinary incontinence comprising injecting a proliferative agent in supportive tissue that supports a tissue selected from the group consisting of:

a urethra, bladder, and pelvic floor tissue;

wherein the proliferative agent results in shrinkage of collagen of the supportive tissue, which treats the urinary incontinence.

2. The method of claim 1, comprising injecting the proliferative agent into a wall of the urethra.

3. The method of claim 2 wherein the step of injecting the proliferative agent into a wall of the urethra comprises injecting the proliferative agent into a wall of the urethra using a plurality of small needles.

4. The method of claim 3 wherein the proliferative agent is injected around all sides of and into the wall of the urethra using the plurality of small needles.

5. The method of claim 2, further comprising introduction of an inflatable marking device into the urethra to identify the walls of the urethra.

6. The method of claim 1, wherein said proliferative agent is selected from the group including saline, dextrose, phenol, glycerine, and morrhuate sodium.

7. The method of claim 1, wherein said proliferative agent is selected from the group including dextrose, phenol, glycerine, and morrhuate sodium.

8. A method of claim 1 wherein the supportive tissue is selected from the group consisting of:

pubocervical fascia, a pubourethral ligament, a lateral pubovesical ligament, an arcus tendon of a levator ani muscle, and a perineal floor.